← Tomasz J. Guzik

Papers by Tomasz J. Guzik

Page 2 · newest first

51. Red blood cell distribution width is associated with increased interactions of blood cells with vascular wallScientific Reports · 2022
52. The backstage of the Russian–Ukrainian war: refugees in urgent need of cardiovascular managementCardiovascular Research · 2022
53. Kidney omics in hypertension: from statistical associations to biological mechanisms and clinical applicationsKidney International · 2022
54. Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanismJournal of Clinical Investigation · 2022
55. Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and MicrocirculationCardiovascular Research · 2022
56. Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trialEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2022
57. Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trialsPharmacological Research · 2021
58. The Th17/Treg imbalance in patients with primary hyperaldosteronism and resistant hypertensionPolskie Archiwum Medycyny Wewnętrznej · 2021
59. Periodontitis as an inflammatory trigger in hypertension: From basic immunology to clinical implicationsKardiologia Polska · 2021
60. Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspectiveCardiovascular Research · 2021
61. IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in MiceHypertension · 2021
62. Molecular imaging of cardiovascular inflammationBritish Journal of Pharmacology · 2021
63. Nanoparticle theranostics in cardiovascular inflammationSeminars in Immunology · 2021
64. Central role of c-Src in NOX5- mediated redox signalling in vascular smooth muscle cells in human hypertensionCardiovascular Research · 2021
65. Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for HypertensionHypertension · 2021
66. Erratum to: Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of EvidenceCardiovascular Research · 2021
67. Mounting Pressure of PeriodontitisHypertension · 2021
68. Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19CJC Open · 2021
69. Immune spleen cells attenuate the inflammatory profile of the mesenteric perivascular adipose tissue in obese miceScientific Reports · 2021
70. A Call to Action for New Global Approaches to Cardiovascular Disease Drug SolutionsENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2021
71. Silencing of Sphingosine kinase 1 Affects Maturation Pathways in Mouse Neonatal CardiomyocytesInternational Journal of Molecular Sciences · 2021
72. Echocardiography Predictors of Survival in Hypertensive Patients With Left Ventricular HypertrophyAmerican Journal of Hypertension · 2021
73. Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasiaCardiovascular Research · 2021
74. A call to action for new global approaches to cardiovascular disease drug solutionsEuropean Heart Journal · 2021
75. Impact of Acute Total Occlusion of Culprit Artery on Outcome in NSTEMI – Results From a Large National Registry2021
76. Nox1/4 inhibition exacerbates age dependent perivascular inflammation and fibrosis in a model of spontaneous hypertensionPharmacological Research · 2020
77. Is systemic inflammation a missing link between periodontitis and hypertension? Results from two large population‐based surveysENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2020
78. Why do some asthma patients respond poorly to glucocorticoid therapy?Pharmacological Research · 2020
79. Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: mechanistic insights and implications for anti-thrombotic treatmentCardiovascular Research · 2020
80. ESC Core Curriculum for the CardiologistEuropean Heart Journal · 2020
81. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular ScienceCardiovascular Research · 2020
82. Active gingival inflammation is linked to hypertensionJournal of Hypertension · 2020
83. Hypertension and renin-angiotensin system blockers are not associated with expression of Angiotensin Converting Enzyme 2 (ACE2) in the kidney2020
84. Leaders in Cardiovascular Research: Valentin FusterCardiovascular Research · 2020
85. Oleacein and Foam Cell Formation in Human Monocyte-Derived Macrophages: A Potential Strategy against Early and Advanced Atherosclerotic LesionsPharmaceuticals · 2020
86. Significance of sphingosine-1-phosphate in cardiovascular physiology and pathologyPharmacological Research · 2020
87. Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery diseaseCardiovascular Research · 2020
88. Endothelial function in cardiovascular medicine: a consensus paper of the European Society of Cardiology Working Groups on Atherosclerosis and Vascular Biology, Aorta and Peripheral Vascular Diseases, Coronary Pathophysiology and Microcirculation, and ThrombosisCardiovascular Research · 2020
89. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implicationsCardiovascular Research · 2020
90. Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19Cardiovascular Research · 2020
91. Inside the heart of COVID-19Cardiovascular Research · 2020
92. Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular DiseaseCirculation · 2020
93. White Blood Cells and Blood PressureENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2020
94. Cytokines at the Interplay Between Asthma and Atherosclerosis?Frontiers in Pharmacology · 2020
95. T-Cell–Derived miRNA-214 Mediates Perivascular Fibrosis in HypertensionENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2020
96. The pathogenic role of coronary microvascular dysfunction in the setting of other cardiac or systemic conditionsCardiovascular Research · 2020
97. Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory RiskHypertension · 2019
98. Cardiovascular Effects of Pharmacological Targeting of Sphingosine Kinase 1Hypertension · 2019
99. E-vaporating benefits of e-vapingEuropean Heart Journal · 2019
100. Oxidative stress and inflammatory markers in prediabetes and diabetes.ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2019